| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.72B | 89.45B | 79.74B | 79.71B | 72.85B | 58.38B |
| Gross Profit | 47.23B | 45.84B | 40.45B | 39.29B | 37.19B | 31.31B |
| EBITDA | 27.03B | 26.72B | 23.46B | 23.08B | 22.87B | 20.77B |
| Net Income | 14.75B | 14.44B | 14.50B | 14.46B | 12.67B | 11.38B |
Balance Sheet | ||||||
| Total Assets | 142.16B | 162.51B | 132.64B | 137.96B | 138.60B | 125.20B |
| Cash, Cash Equivalents and Short-Term Investments | 17.52B | 29.84B | 16.34B | 15.38B | 18.54B | 18.79B |
| Total Debt | 3.16B | 3.45B | 3.50B | 3.85B | 3.10B | 4.79B |
| Total Liabilities | 48.95B | 62.93B | 52.50B | 54.63B | 54.58B | 50.05B |
| Stockholders Equity | 92.47B | 98.64B | 78.97B | 81.96B | 82.64B | 73.82B |
Cash Flow | ||||||
| Free Cash Flow | 21.66B | 21.35B | 18.71B | 14.11B | 15.22B | 14.16B |
| Operating Cash Flow | 26.28B | 26.10B | 24.71B | 20.64B | 22.90B | 18.86B |
| Investing Cash Flow | -4.35B | -5.46B | -5.77B | -5.00B | -7.73B | -6.80B |
| Financing Cash Flow | -19.14B | -10.35B | -16.12B | -16.34B | -16.04B | -8.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $122.26B | 17.17 | 8.97% | 1.70% | -2.06% | 21.03% | |
73 Outperform | $35.65B | 13.54 | 15.08% | 2.06% | -0.79% | -10.83% | |
71 Outperform | $2.30B | 14.60 | 10.15% | 3.69% | 13.92% | 32.69% | |
71 Outperform | $19.79B | 35.11 | 6.88% | 4.76% | -2.73% | -37.93% | |
66 Neutral | $9.24B | 9.18 | 7.79% | 3.97% | -5.48% | -6.99% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | $24.78B | 20.66 | 15.91% | 2.90% | -5.57% | 119.49% |
In September 2025, Ambev S.A. reported transactions involving the delivery of restricted shares, with a total of 146,923 shares delivered at a price of R$12.30 each, amounting to a volume of R$1,807,152.90. This transaction reflects Ambev’s ongoing management of its outstanding shares in treasury, impacting its financial operations and potentially influencing shareholder value.
In September 2025, Ambev S.A. reported transactions involving its securities and derivatives, as per CVM Instruction # 358/2002. The transactions were conducted by management and related persons, with notable activities including the sale of 5,000 shares at R$12.50 each through Corretora Itaú. These transactions reflect the company’s ongoing compliance with regulatory requirements and provide insights into the trading activities of its management, potentially impacting investor perceptions and market dynamics.
From August 1st to 31st, 2025, Ambev S.A. reported its transactions involving securities and derivatives, as required by CVM Instruction # 358/2002. The report highlighted that there were no acquisitions or changes in positions by the Board of Directors, Management, or Fiscal Council during this period. This transparency in reporting reflects Ambev’s commitment to regulatory compliance and provides stakeholders with insights into the company’s financial activities.
In August 2025, Ambev S.A. reported transactions involving the delivery of restricted shares, amounting to 24,117 shares at a price of R$12.29 each. This transaction reflects Ambev’s ongoing management of its outstanding shares, with a final balance of 169,352,327 shares. Such activities are part of the company’s strategy to optimize its capital structure and enhance shareholder value.
On August 13 and 14, 2025, Ambev S.A.’s Board of Directors convened to confirm the election of Mr. Guilherme Malik Parente as the Legal and Compliance Vice President Officer, effective September 1, 2025. This appointment is part of a broader reorganization of the company’s executive team, with all officers serving until December 31, 2027. The changes reflect Ambev’s strategic focus on strengthening its leadership and enhancing compliance and governance structures.
During July 2025, Ambev S.A. reported transactions involving securities and derivatives by its management and related persons, in compliance with regulatory requirements. The transactions included the sale of shares through Itaú Corretora, resulting in a decrease in the number of shares held by management. These activities reflect Ambev’s adherence to transparency and regulatory compliance, potentially impacting stakeholders’ perceptions of the company’s governance practices.
In July 2025, Ambev S.A. reported transactions involving its securities and derivatives, specifically the delivery of restricted shares. The company executed a transaction of 52,524 common shares at a price of R$13.38 per share, amounting to a total volume of R$702,771.12. This activity reflects Ambev’s ongoing management of its outstanding shares and treasury operations, which may impact its market positioning and shareholder value.
On August 1, 2025, Ambev S.A. released its interim consolidated financial statements for the period ending June 30, 2025. The review, conducted by PricewaterhouseCoopers, concluded that the financial statements were prepared in accordance with International Accounting Standard 34. The report highlighted a decrease in total assets from December 2024 to June 2025, reflecting changes in cash and cash equivalents, trade receivables, and other financial instruments. This financial update provides stakeholders with insights into the company’s current financial health and operational adjustments.
Ambev S.A. released an updated report on its adherence to the Brazilian Code of Corporate Governance as of July 31, 2025. The report highlights the company’s practices regarding shareholder agreements, meetings, and change of control policies. It emphasizes that while certain governance practices are adopted, others are not, such as the Board of Directors’ obligation to provide opinions on public offerings for acquisition. The report underscores the company’s commitment to maximizing business opportunities and enhancing shareholder value, particularly for minority shareholders, through compliance with legal mechanisms in change of control scenarios.
Ambev S.A. submitted a report to the Securities and Exchange Commission for July 2025, signed by Guilherme Fleury de Figueiredo Ferraz Parolari, the Chief Financial and Investor Relations Officer. This filing is part of the company’s compliance with the Securities Exchange Act of 1934, indicating its ongoing commitment to regulatory transparency and investor communication.
On July 30, 2025, Ambev S.A. announced that its Board of Directors approved a dividend distribution of R$ 0.1283 per share, based on the extraordinary balance sheet as of June 30, 2025. The payment is scheduled for October 6, 2025, with shares and ADRs to be traded ex-dividends starting August 8, 2025. This decision reflects the company’s financial performance in the first half of 2025 and underscores its commitment to returning value to shareholders.
Ambev S.A. reported its second-quarter results for 2025, highlighting a 7.6% growth in Normalized EBITDA and a 15.2% increase in Normalized Profit, despite a 4.5% decline in consolidated volumes due to softer industries. The company achieved a 3.4% increase in net revenue, driven by strategic revenue management and premiumization efforts, while also announcing intermediary dividends to be paid in October. The digital transformation and brand activations have contributed to the company’s resilience, with significant growth in premium and super-premium brands and digital platforms like Zé Delivery.
On July 30, 2025, Ambev S.A.’s Board of Directors approved the preparation of an extraordinary balance sheet as of June 30, 2025, and the distribution of dividends amounting to R$ 0.1283 per share. This decision is based on the company’s financial performance in the first half of 2025 and reflects its commitment to returning value to shareholders. The dividends will be paid on October 6, 2025, with shares and ADRs trading ex-dividends starting August 8, 2025. This move underscores Ambev’s robust financial health and strategic focus on shareholder returns.